Results 211 to 220 of about 463,152 (355)
We investigated the toxicity of 12 active compounds commonly found in herbal weight loss supplements (WLS) using human liver and colon cell models. Epigallocatechin‐3‐gallate was the only compound showing significant toxicity. Metabolic profiling revealed protein degradation, disrupted energy and lipid metabolism suggesting that the inclusion of EGCG ...
Emily C. Davies +3 more
wiley +1 more source
A minimum catalytic unit for synthesis of InsP6 and 5-PP-InsP5 in Arabidopsis. [PDF]
Whitfield HL +5 more
europepmc +1 more source
KLK7, a tissue kallikrein‐related peptidase, is elevated in advanced colorectal cancer and associated with shorter survival. High KLK7 levels in ascites correlate with peritoneal metastasis. In mice, KLK7 overexpression increases metastasis. In vitro, KLK7 enhances cancer cell proliferation, migration, adhesion, and spheroid formation, driving ...
Yosr Z. Haffani +6 more
wiley +1 more source
A DFT study on the base-catalyzed allylic rearrangement reaction of enol phosphate. [PDF]
Wang K +6 more
europepmc +1 more source
CRISPRI‐mediated gene silencing and phenotypic exploration in nontuberculous mycobacteria. In this Research Protocol, we describe approaches to control, monitor, and quantitatively assess CRISPRI‐mediated gene silencing in M. smegmatis and M. abscessus model organisms.
Vanessa Point +7 more
wiley +1 more source
Une campagne de prospection électrique de type Schlumberger a été réalisée sur une zone couvrant une surface 50 ha dans le bassin phosphatier Oulad Abdoun.
Saad Bakkali, Mahacine Amrani
doaj
The Exceptional Solubility of Cyclic Trimetaphosphate in the Presence of Mg<sup>2+</sup> and Ca<sup>2</sup>. [PDF]
Bachant MG, Müller UF.
europepmc +1 more source
NF90–NF45 functions as a negative regulator of methyltransferase‐like 3/14 (METTL3/14)‐mediated N6‐methyladenosine (m6A) modification on primary microRNAs (pri‐miRNAs). NF90–NF45 binds to anti‐oncogenic pri‐miRNAs and inhibits their m6A modification, thereby suppressing the biogenesis of anti‐oncogenic miRNAs.
Takuma Higuchi +6 more
wiley +1 more source

